144 ·Filed Jun 30, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
Routine insider sale for tax/planning purposes from RSU vesting; no material directional signal. Monitor for any subsequent larger non-RSU sales.
Final — all horizons settled through T+60d
CLYM ▼ -10.53% at T+60d
NEUTRAL call -10.53% · α vs SPY -13.49% · entry $13.29 → $11.89
T+1d
-2.93%
call -2.93% · α -2.80%
$12.90
settled 4mo ago
T+5d
+0.98%
call +0.98% · α +0.72%
$13.42
settled 4mo ago
T+20d
-8.88%
call -8.88% · α -6.69%
$12.11
settled 3mo ago
T+60d
-10.53%
call -10.53% · α -13.49%
$11.89
settled 5w ago
Price Chart
Loading chart...
Executive Summary
Insider Aoife Brennan (officer/director) filed a Form 144 indicating intent to sell 30,902 shares of Climb Bio common stock, valued at approximately $407k, from RSU vesting on June 27, 2026. The sale appears routine and small relative to market cap (~$765M), not signaling material insider concern.
Key Facts
- Filer: Aoife Brennan, officer and director
- Proposed sale of 30,902 shares of common stock
- Estimated market value: $406,967.50
- Shares acquired via RSU vesting on June 27, 2026
- Filed on June 30, 2026; sale intended within 90 days
Financial Impact
~0.05% of market cap, $407k
dilution (negligible)
Risk Factors
- No material risk identified
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001193125-26-291127 |
| Document: 0001193125-26-291127-index.html | 0001193125-26-291127 |
| Document: 0001193125-26-291127.txt | 0001193125-26-291127 |
21 reports for CLYM
88% Hit rate @ T+1 Went positive at some point 7 of 8 best @ T+1▲ +8.63%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G | $9.60 | awaiting T+1 | — | $9.57 (−0.31%) |
Oct 26, 2026 1d ago | 8-K | $8.81 $9.57 | ▲ +8.63% | ▲ +8.07% | $9.57 (+8.63%) |
Oct 23, 2026 4d ago | 8-K | $8.81 $9.57 | ▲ +8.63% | ▲ +8.07% | $9.57 (+8.63%) |
Oct 23, 2026 4d ago | Press Release | $8.81 $9.57 | ▲ +8.63% | ▲ +8.07% | $9.57 (+8.63%) |
Sep 22, 2026 5w ago | Institutional Cluster | $14.21 $12.52 | ▼ −11.89% | ▼ −11.17% | $9.57 (−32.65%) |
Sep 3, 2026 7w ago | 8-K | $14.59 $15.52 | ▲ +6.37% | ▲ +6.76% | $9.57 (−34.41%) |
Aug 14, 2026 10w ago | 8-K | $16.33 $17.44 | ▲ +6.80% | ▲ +7.27% | $9.57 (−41.40%) |
Aug 6, 2026 11w ago | 8-K | $14.00 $14.00 | · 0.00% | ▼ −0.61% | $9.57 (−31.64%) |
Jun 30, 2026 17w ago | 144 | $13.29 $12.90 | ▼ −2.93% | ▼ −2.80% | $9.57 (−27.99%) |
Jun 12, 2026 19w ago | 8-K | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $9.57 (+16.71%) |
Showing 10 of 21
US Market Status
Market Closed — Opens in 8h 23m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers